AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart Failure Gene Therapy

2 days ago

Add Comment

by David Miller

945 Views

SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

You may also like

About the author

David Miller

Leave a Comment X

Don`t Leave Yet!